ARTHUR PRZYBYL Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ARTHUR PRZYBYL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ARTHUR PRZYBYL. ARTHUR PRZYBYL is President, CEO in AKORN INC ($AKRN.PK) and President and CEO in ANI PHARMACEUTICALS INC ($ANIP).
Latest Insider Trading Transactions of ARTHUR PRZYBYL
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 08 2020 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 43.93 | 2,115 | 92,912 | 190,309 | 192.4 K to 190.3 K (-1.10 %) |
Apr 08 2020 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 43.22 | 3,282 | 141,848 | 192,424 | 195.7 K to 192.4 K (-1.68 %) |
Mar 31 2020 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 40.74 | 2,679 | 109,142 | 195,706 | 198.4 K to 195.7 K (-1.35 %) |
Mar 31 2020 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 37.76 | 4,204 | 158,743 | 198,385 | 202.6 K to 198.4 K (-2.08 %) |
Mar 31 2020 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 40.74 | 2,679 | 109,142 | 195,706 | 198.4 K to 195.7 K (-1.35 %) |
Mar 31 2020 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 37.76 | 4,204 | 158,743 | 198,385 | 202.6 K to 198.4 K (-2.08 %) |
May 15 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Sell | S | 69.25 | 14,633 | 1,013,335 | 202,589 | 217.2 K to 202.6 K (-6.74 %) |
May 15 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Sell | S | 70.45 | 5,772 | 406,637 | 217,222 | 223 K to 217.2 K (-2.59 %) |
May 15 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Sell | S | 71.10 | 9,595 | 682,205 | 222,994 | 232.6 K to 223 K (-4.13 %) |
Apr 18 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 68.60 | 1,692 | 116,071 | 232,589 | 234.3 K to 232.6 K (-0.72 %) |
Apr 09 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 70.50 | 2,115 | 149,108 | 234,281 | 236.4 K to 234.3 K (-0.89 %) |
Apr 09 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 70.50 | 3,282 | 231,381 | 236,396 | 239.7 K to 236.4 K (-1.37 %) |
Apr 02 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 70.54 | 2,678 | 188,906 | 239,678 | 242.4 K to 239.7 K (-1.10 %) |
Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Option Exercise | A | 66.39 | 45,106 | 2,994,587 | 45,106 | |
Apr 01 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Grant | A | 0.00 | 37,280 | 0 | 242,356 | 205.1 K to 242.4 K (+18.18 %) |
Mar 20 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Option Exercise | M | 49.51 | 2,823 | 139,767 | 35,625 | |
Mar 20 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Option Exercise | M | 49.51 | 9,052 | 448,165 | 38,448 | |
Mar 20 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Option Exercise | M | 40.59 | 9,375 | 380,531 | 18,750 | |
Mar 20 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Option Exercise | M | 33.00 | 6,375 | 210,375 | 0 | |
Mar 20 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Sell | S | 63.51 | 2,823 | 179,289 | 205,076 | 207.9 K to 205.1 K (-1.36 %) |
Mar 20 2019 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Sell | S | 63.53 | 24,802 | 1,575,671 | 205,076 | 229.9 K to 205.1 K (-10.79 %) |
May 24 2018 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 61.88 | 1,375 | 85,085 | 207,256 | 208.6 K to 207.3 K (-0.66 %) |
Apr 18 2018 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 60.21 | 1,611 | 96,998 | 208,631 | 210.2 K to 208.6 K (-0.77 %) |
Apr 10 2018 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Option Exercise | A | 57.06 | 35,200 | 2,008,512 | 35,200 | |
Apr 10 2018 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 57.06 | 2,014 | 114,919 | 210,242 | 212.3 K to 210.2 K (-0.95 %) |
Apr 10 2018 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Grant | A | 0.00 | 29,100 | 0 | 212,256 | 183.2 K to 212.3 K (+15.89 %) |
Mar 14 2018 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Option Exercise | M | 6.36 | 15,723 | 99,998 | 0 | |
Mar 14 2018 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Sell | S | 62.03 | 10,000 | 620,300 | 185,706 | 195.7 K to 185.7 K (-5.11 %) |
Mar 14 2018 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Sell | S | 62.63 | 6,525 | 408,661 | 195,706 | 202.2 K to 195.7 K (-3.23 %) |
Mar 14 2018 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Sell | S | 61.52 | 23,475 | 1,444,182 | 202,231 | 225.7 K to 202.2 K (-10.40 %) |
Mar 14 2018 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Buy | M | 6.36 | 15,723 | 99,998 | 225,706 | 210 K to 225.7 K (+7.49 %) |
Mar 05 2018 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Option Exercise | M | 6.36 | 8,236 | 52,381 | 15,723 | |
Mar 05 2018 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Option Exercise | M | 33.00 | 6,375 | 210,375 | 6,375 | |
Mar 05 2018 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Option Exercise | M | 40.59 | 9,375 | 380,531 | 28,125 | |
Mar 05 2018 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Sell | S | 62.17 | 4,260 | 264,844 | 209,983 | 214.2 K to 210 K (-1.99 %) |
Mar 05 2018 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Sell | S | 61.62 | 8,400 | 517,608 | 214,243 | 222.6 K to 214.2 K (-3.77 %) |
Mar 05 2018 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Sell | S | 60.59 | 11,326 | 686,242 | 222,643 | 234 K to 222.6 K (-4.84 %) |
Mar 05 2018 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Buy | M | 6.36 | 8,236 | 52,381 | 233,969 | 225.7 K to 234 K (+3.65 %) |
Mar 05 2018 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Buy | M | 33.00 | 6,375 | 210,375 | 225,733 | 219.4 K to 225.7 K (+2.91 %) |
Mar 05 2018 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Buy | M | 40.59 | 9,375 | 380,531 | 219,358 | 210 K to 219.4 K (+4.46 %) |
May 24 2017 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 47.01 | 991 | 46,587 | 210,833 | 211.8 K to 210.8 K (-0.47 %) |
Apr 18 2017 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 51.22 | 1,161 | 59,466 | 211,824 | 213 K to 211.8 K (-0.55 %) |
Apr 11 2017 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 51.24 | 1,451 | 74,349 | 212,985 | 214.4 K to 213 K (-0.68 %) |
Aug 23 2016 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Option Exercise | M | 33.00 | 12,750 | 420,750 | 12,750 | |
Aug 23 2016 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Option Exercise | M | 6.36 | 15,723 | 99,998 | 23,959 | |
Aug 23 2016 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Option Exercise | M | 6.36 | 24,705 | 157,124 | 39,682 | |
Aug 23 2016 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Sell | S | 66.97 | 37,455 | 2,508,361 | 191,806 | 229.3 K to 191.8 K (-16.34 %) |
Aug 23 2016 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Buy | M | 33.00 | 12,750 | 420,750 | 229,261 | 216.5 K to 229.3 K (+5.89 %) |
Aug 23 2016 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Buy | M | 6.36 | 15,723 | 99,998 | 216,511 | 200.8 K to 216.5 K (+7.83 %) |
Aug 23 2016 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Buy | M | 6.36 | 24,705 | 157,124 | 200,788 | 176.1 K to 200.8 K (+14.03 %) |
Aug 09 2016 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Gift | G | 0.00 | 836 | 0 | 176,083 | 176.9 K to 176.1 K (-0.47 %) |
May 24 2016 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 49.54 | 991 | 49,094 | 176,919 | 177.9 K to 176.9 K (-0.56 %) |
Apr 18 2016 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 43.25 | 1,161 | 50,213 | 177,910 | 179.1 K to 177.9 K (-0.65 %) |
Apr 11 2016 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Option Exercise | A | 40.59 | 37,500 | 1,522,125 | 37,500 | |
Apr 11 2016 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Grant | A | 0.00 | 18,750 | 0 | 179,071 | 160.3 K to 179.1 K (+11.70 %) |
Jan 11 2016 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Option Exercise | M | 6.36 | 16,446 | 104,597 | 64,387 | |
Jan 11 2016 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Buy | M | 6.36 | 16,446 | 104,597 | 160,321 | 143.9 K to 160.3 K (+11.43 %) |
Dec 15 2015 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Gift | G | 0.00 | 1,320 | 0 | 143,875 | 145.2 K to 143.9 K (-0.91 %) |
Nov 12 2015 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Buy | P | 40.95 | 2,500 | 102,375 | 145,195 | 142.7 K to 145.2 K (+1.75 %) |
Aug 10 2015 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Option Exercise | M | 6.36 | 10,000 | 63,600 | 80,833 | |
Aug 10 2015 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Buy | M | 6.36 | 10,000 | 63,600 | 142,695 | 132.7 K to 142.7 K (+7.54 %) |
May 27 2015 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Payment of Exercise | F | 53.10 | 1,469 | 78,004 | 132,695 | 134.2 K to 132.7 K (-1.09 %) |
May 08 2015 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Option Exercise | M | 6.36 | 5,000 | 31,800 | 90,833 | |
May 08 2015 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Buy | M | 6.36 | 5,000 | 31,800 | 134,164 | 129.2 K to 134.2 K (+3.87 %) |
Apr 20 2015 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Option Exercise | A | 68.71 | 30,000 | 2,061,300 | 30,000 | |
Apr 20 2015 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Grant | A | 0.00 | 15,000 | 0 | 129,164 | 114.2 K to 129.2 K (+13.14 %) |
Mar 16 2015 | ANIP | ANI PHARMACEUTICAL ... | PRZYBYL ARTHUR | President and CEO | Sell | S | 63.00 | 75,000 | 4,725,000 | 114,164 | 189.2 K to 114.2 K (-39.65 %) |
Jun 24 2008 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Sell | S | 3.33 | 21,152 | 70,362 | 222,740 | 243.9 K to 222.7 K (-8.67 %) |
Jun 24 2008 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Sell | S | 3.41 | 251,850 | 859,841 | 243,892 | 495.7 K to 243.9 K (-50.80 %) |
Apr 22 2008 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Payment of Exercise | F | 5.03 | 21,531 | 108,301 | 495,742 | 517.3 K to 495.7 K (-4.16 %) |
Dec 19 2007 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Option Exercise | M | 0.80 | 50,000 | 40,000 | 0 | |
Dec 19 2007 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Option Exercise | M | 0.90 | 25,000 | 22,500 | 0 | |
Dec 19 2007 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Buy | M | 0.80 | 50,000 | 40,000 | 517,273 | 467.3 K to 517.3 K (+10.70 %) |
Dec 19 2007 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Buy | M | 0.90 | 25,000 | 22,500 | 467,273 | 442.3 K to 467.3 K (+5.65 %) |
Apr 24 2007 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Payment of Exercise | F | 7.38 | 43,062 | 317,798 | 442,273 | 485.3 K to 442.3 K (-8.87 %) |
Jan 04 2007 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Option Exercise | A | 6.25 | 400,000 | 2,500,000 | 400,000 | |
Dec 14 2006 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Option Exercise | M | 1.20 | 125,000 | 150,000 | 0 | |
Dec 14 2006 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Option Exercise | M | 1.00 | 175,000 | 175,000 | 0 | |
Dec 14 2006 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Sell | S | 0.00 | 300,000 | 0 | 485,335 | 785.3 K to 485.3 K (-38.20 %) |
Dec 14 2006 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Buy | M | 1.20 | 125,000 | 150,000 | 785,335 | 660.3 K to 785.3 K (+18.93 %) |
Dec 14 2006 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Buy | M | 1.00 | 175,000 | 175,000 | 660,335 | 485.3 K to 660.3 K (+36.06 %) |
Apr 24 2006 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Option Exercise | A | 5.05 | 500,000 | 2,525,000 | 500,000 | |
Apr 24 2006 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Grant | A | 0.00 | 250,000 | 0 | 485,335 | 235.3 K to 485.3 K (+106.23 %) |
Apr 12 2006 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Payment of Exercise | F | 4.86 | 17,207 | 83,626 | 235,335 | 252.5 K to 235.3 K (-6.81 %) |
Dec 20 2005 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Option Exercise | X | 1.00 | 35,000 | 35,000 | 0 | |
Dec 20 2005 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Option Exercise | C | 0.75 | 1,050 | 788 | 0 | |
Dec 20 2005 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Buy | X | 0.00 | 27,117 | 0 | 252,542 | 225.4 K to 252.5 K (+12.03 %) |
Dec 20 2005 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Buy | C | 0.00 | 159,549 | 0 | 225,425 | 65.9 K to 225.4 K (+242.20 %) |
Jul 13 2004 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Option Exercise | J | 0.75 | 48 | 36 | 1,313,794 | |
Jul 13 2004 | AKRN.PK | AKORN INC | PRZYBYL ARTHUR | President, CEO | Option Exercise | A | 2.00 | 750,000 | 1,500,000 | 1,313,794 |
Page: 1